MRNA
Moderna Inc
198.90$
+2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +53.6% | -94.1% | +32.3% | +739.4% | -48.5% | -88.8% | +32.7% | +615.5% | -33.3% | -42.6% | -62.7% | – | |
| – | -58.5% | -89.7% | +19.8% | +347.0% | +43.8% | -87.8% | +32.2% | +747.1% | -55.2% | +111.3% | -90.3% | – | |
| – | – | -96.2% | +49.3% | +1,165.1% | -83.8% | -92.2% | +35.3% | -65.2% | +2,725.0% | -350.4% | – | – | |
| – | +21.2% | -27.0% | +18.9% | -6.9% | -1.3% | -23.7% | -18.2% | +14.4% | -3.2% | -16.3% | +0.3% | – | |
| – | -39.8% | +3.0% | -2.2% | +4.9% | +24.9% | -39.6% | +8.5% | +16.5% | +14.9% | -43.8% | +24.9% | – | |
| – | +17.2% | -28.8% | +9.9% | -3.9% | +3.7% | -27.1% | -12.8% | -71.2% | +304.1% | -24.1% | +5.5% | – | |
| – | – | -21,200.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -40.0% | +0.0% | +0.0% | +0.0% | +0.0% | -83.3% | +0.0% | -100.0% | – | +112.5% | +0.0% | – | |
| – | – | -1,764.3% | – | – | -5,738.1% | – | – | – | – | – | – | – | |
| – | -108.8% | – | – | – | -900.0% | – | +0.0% | +85.7% | +107.7% | -66.7% | +66.7% | – | |
| – | – | -641.5% | – | – | -8,715.4% | – | – | – | – | – | – | – | |
| – | – | -504.0% | – | – | -1,515.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.